Private equity firm Odyssey Investment Partners agreed to acquire ProPharma Group, a provider of regulatory and compliance services to pharmaceutical, biotechnology and medical device customers, from Linden Capital Partners. Financial terms were not disclosed. "ProPharma Group represents a compelling opportunity to invest in a growing business with attractive demand characteristics given its critical role in helping customers comply with regulatory and safety requirements. Dawn and the management team have done an outstanding job of establishing a comprehensive offering of services in a large, growing and fragmented industry. We have identified numerous organic and inorganic opportunities to build on ProPharma Group's leadership position by expanding its four business verticals and expect to capitalize on these in the coming years," Jeffrey McKibben, Odyssey Senior Managing Principal.